SLC45A3 antibody (C-Term, N-Term)

Catalog No. ABIN1738434

Product Details anti-SLC45A3 Antibody

Target: SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))

Binding Specificity: C-Term, N-Term

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This SLC45A3 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Specificity: Reacts with human Prostein.

Purification: Purified

Immunogen: N-terminal sequence ITYVPPLLLEVGVEE and C-terminal sequence FATQVVFDKSDLAKYSA of human prostein.

Isotype: IgG

Application Details

Application Notes: Working dilution: - WB: 1:500-1:1,000 - ELISA: 1:1,000-1:5,000

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C/-20 °C

Target Details for SLC45A3

Target: SLC45A3 (Solute Carrier Family 45, Member 3 (SLC45A3))

Alternative Name: Prostein (SLC45A3 Products)

Synonyms: MGC68967 antibody, zgc:162897 antibody, IPCA-2 antibody, IPCA-6 antibody, IPCA-8 antibody, IPCA6 antibody, PCANAP2 antibody, PCANAP6 antibody, PCANAP8 antibody, PRST antibody, 2210413P12Rik antibody, AU023994 antibody, AU043764 antibody, Pcanap6 antibody, RGD1309764 antibody, solute carrier family 45 member 3 L homeolog antibody, solute carrier family 45 member 3 antibody, solute carrier family 45, member 3 antibody, slc45a3.L antibody, SLC45A3 antibody, slc45a3 antibody, Slc45a3 antibody

Background: Prostein is a novel prostate-specific protein expressed in normal and malignant prostate tissues. This protein appears to be a type IIIa plasma membrane protein with a cleavable signal peptide and 11 transmembrane-spanning regions. Prostein expression is androgen responsive since treatment of LNCaP cells with androgen up-regulates prostein message and protein expression levels. Thus, prostein is a prostate-specific marker whose detection and quantitation may be useful in diagnosing and monitoring prostate cancer.